Pascal Lenain

5k citations
90 papers · 4k · 1 hit paper · h-index 27

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
    • Lymphoma Diagnosis and Treatment

Papers in

    • Multiple Myeloma Research and Treatments 37
    • Chronic Myeloid Leukemia Treatments 12
    • Acute Myeloid Leukemia Research 6
    • Hematopoietic Stem Cell Transplantation 3
    • Lymphoma Diagnosis and Treatment 11

Pascal Lenain

86 papers receiving 3.9k citations

Pascal Lenain's Hit Papers

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study 2019 · 773 citations
7730+2+4Years since publication250500750

Peers

Pascal Lenain
Comparison fields: 5 of 69
  • Hematology 2.9k
  • Pathology and Forensic Medicine 458
  • Genetics 147
  • Oncology 164
  • Family Practice 15
Replace Nathalie Contentin with:
Nathalie Contentin France
Patrizia Pregno Italy
Ann Hunter United Kingdom
Rolf Kuse Germany
Itai Levi Israel
Jenny Byrne United Kingdom
Patrizio Mazza Italy
Mario Annunziata Italy
Senji Kasahara Japan
Sumithira Vasu United States
Pascal Lenain relative to Nathalie Contentin France Nathalie Contentin's profile →
Citations per field
00.5×1.5×
Nathalie Contentin · 1×
Citations per year

Countries citing papers authored by Pascal Lenain

Since Specialization
Citations

This map shows the geographic impact of Pascal Lenain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Lenain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Lenain more than expected).

Fields of papers citing papers by Pascal Lenain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Lenain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Lenain. The network helps show where Pascal Lenain may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Lenain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Lenain Line = papers co-authored together Pascal Lenain links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Hit paper breakdown →
2019773
2 2010461
3 2009330
4 2011264
5 2016225
6 2009135
7
patients with the description of a new scoring system and its validation on 253 other patients.
2000121
8 2014117
9 2010112
10 2019100
11 201886
12 200683
13 202075
14 200269
15 200068
16 201661
17 200058
18 201854
19 201545
20 200244

About Pascal Lenain

Pascal Lenain is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Infectious Diseases, having authored 90 papers that have together received 4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Chronic Myeloid Leukemia Treatments (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (6 papers), Antifungal resistance and susceptibility (3 papers), Nutrition and Health in Aging (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (2.9k citations), Pathology and Forensic Medicine (458 citations), Genetics (147 citations), Oncology (164 citations) and Family Practice (15 citations). Pascal Lenain has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Thierry T.F. Facon, Philippe Moreau, Philippe Casassus, Cyrille Hulin, Lotfi Benboubker, Claire Mathiot, Hervé Tilly, Aspasia Stamatoullas, Stéphane Leprêtre and Fabrice Jardin. Their work appears in journals such as Blood, Leukemia, Haematologica, Clinical Cancer Research and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact